Cervical Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II
Conditions:   CIN3;   Cervical Intraepithelial Neoplasia;   Cervical Intraepithelial Neoplasia Grade 3;   HPV 16 Infection Intervention:   Biological: Vvax001 therapeutic cancer vaccine Sponsors:   University Medical Center Groningen;   Dutch Cancer Society;   ViciniVax B.V Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials